Safety and long-term efficacy of autologous hematopoietic cell transplantation for patients with systemic sclerosis

Safety and long-term efficacy of autologous hematopoietic cell transplantation for patients with systemic sclerosis

Autologous hematopoietic cell transplantation (HCT) has been introduced for patients with severe systemic sclerosis (SSc). We aimed to assess the safety and long-term efficacy of HCT modality for severe SSc, refractory to conventional therapy, in 17 patients who were referred to our – The Joint Accr...

Full description

Saved in:
Bibliographic Details
Main Authors: Eleni Gavriilaki, Despina Mallouri, Ioannis Batsis, Zoi Bousiou, Anna Vardi, Nikolaos Spyridis, Georgios Karavalakis, Alkistis kyra Panteliadou, Panagiotis Dolgyras, Christos Varelas, Vlasios I. Alevizopoulos, Panagiotis G. Asteris, Panayiotis Vlachoyiannopoulos, Damianos Sotiropoulos, Petros P. Sfikakis, Ioanna Sakellari
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-07-01
Series:Frontiers in Medicine
Subjects:
cell therapy
hematopoietic cell transplantation
systemic sclerosis
scleroderma
treatment-related mortality
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2025.1527779/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2025.1527779/full

Similar Items